RONCHETTI, DOMENICA
RONCHETTI, DOMENICA
Dipartimento di Oncologia ed Emato-Oncologia
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers
2024 D. Ronchetti, V. Traini, I. Silvestris, G. Fabbiano, F. Passamonti, N. Bolli, E. Taiana
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins
2023 E. Taiana, C. Bandini, V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, K. Todoerti, S. Erratico, D. Giannandrea, N. Bolli, N. Amodio, A. Ciarrocchi, R. Chiaramonte, Y. Torrente, R. Piva, A. Neri
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma
2023 N. Platonova, E. Lazzari, M. Colombo, M. Falleni, D. Tosi, D. Giannandrea, V. Citro, L. Casati, D. Ronchetti, N. Bolli, A. Neri, F. Torricelli, L.A. Crews, C.H.M. Jamieson, R. Chiaramonte
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification
2023 V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, G. Fabbiano, V. Traini, K. Todoerti, S. Erratico, A. Ciarrocchi, V. Fragliasso, D. Giannandrea, F. Tumiatti, R. Chiaramonte, Y. Torrente, P. Finelli, E. Morelli, N.C. Munshi, N. Bolli, A. Neri, E. Taìana
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma
2022 D. Ronchetti, V.K. Favasuli, I. Silvestris, K. Todoerti, F. Torricelli, N. Bolli, A. Ciarrocchi, E. Taiana, A. Neri
In Vitro Silencing of lncRNAs Using LNA GapmeRs
2021 E. Taiana, V. Favasuli, D. Ronchetti, E. Morelli, P. Tassone, G. Viglietto, N.C. Munshi, A. Neri, N. Amodio
Mechanisms of immune evasion in multiple myeloma : Open questions and therapeutic opportunities
2021 C. Botta, F. Mendicino, E.A. Martino, E. Vigna, D. Ronchetti, P. Correale, F. Morabito, A. Neri, M. Gentile
Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs
2021 P. D'Aquila, D. Ronchetti, M.E. Gallo Cantafio, K. Todoerti, E. Taiana, F. Fabiani, A. Montesanto, A. Neri, G. Passarino, G. Viglietto, D. Bellizzi, N. Amodio
Dissecting the biological relevance and clinical impact of lncrna miat in multiple myeloma
2021 K. Todoerti, D. Ronchetti, N. Puccio, I. Silvestris, V. Favasuli, N. Amodio, M. Gentile, F. Morabito, A. Neri, E. Taiana
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome
2021 K. Todoerti, D. Ronchetti, V. Favasuli, F. Maura, F. Morabito, N. Bolli, E. Taiana, A. Neri
Transcriptomic analysis in multiple myeloma and primary plasma cell leukemia with t(11;14) reveals different expression patterns with biological implications in venetoclax sensitivity
2021 K. Todoerti, E. Taiana, N. Puccio, V. Favasuli, M. Lionetti, I. Silvestris, M. Gentile, P. Musto, F. Morabito, U. Gianelli, N. Bolli, L. Baldini, A. Neri, D. Ronchetti
Bioinformatics Pipeline to Analyze lncRNA Arrays
2021 K. Todoerti, D. Ronchetti, M. Manzoni, E. Taiana, A. Neri, L. Agnelli
LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?
2020 E. Taiana, D. Ronchetti, K. Todoerti, L. Nobili, P. Tassone, N. Amodio, A. Neri
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcomek
2020 D. Ronchetti, V. Favasuli, P. Monti, G. Cutrona, S. Fabris, I. Silvestris, L. Agnelli, M. Colombo, P. Menichini, S. Matis, M. Gentile, R. Nurtdinov, R. Guigó, L. Baldini, G. Fronza, M. Ferrarini, F. Morabito, A. Neri, E. Taiana
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma
2020 E. Taiana, V. Favasuli, D. Ronchetti, K. Todoerti, F. Pelizzoni, M. Manzoni, M. Barbieri, S. Fabris, I. Silvestris, M.E. Gallo Cantafio, N. Platonova, V. Zuccalà, L. Maltese, D. Soncini, S. Ruberti, M. Cea, R. Chiaramonte, N. Amodio, P. Tassone, L. Agnelli, A. Neri
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma
2020 D. Ronchetti, K. Todoerti, C. Vinci, V. Favasuli, L. Agnelli, M. Manzoni, F. Pelizzoni, R. Chiaramonte, N. Platonova, N. Giuliani, P. Tassone, N. Amodio, A. Neri, E. Taiana
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma
2019 E. Taiana, D. Ronchetti, V. Favasuli, K. Todoerti, M. Manzoni, N. Amodio, P. Tassone, L. Agnelli, A. Neri
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma
2019 N. Amodio, M.E. Gallo Cantafio, C. Botta, V. Agosti, C. Federico, D. Caracciolo, D. Ronchetti, M. Rossi, C. Driessen, A. Neri, P. Tagliaferri, P. Tassone
Long Non-Coding RNAs in Multiple Myeloma
2018 R. Nobili, D. Ronchetti, L. Agnelli, E. Taiana, C. Vinci, A. Neri
A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma
2018 D. Ronchetti, L. Agnelli, A. Pietrelli, K. Todoerti, M. Manzoni, E. Taiana, A. Neri